Table 2.

Remission Induction With As2O3

Patient No.Treatment ResultsTotal Doses of As2O3 UsedDays to Achieve CRAdditional Treatment
1 CR 280 28 
2 CR 410 41 
3 CR 280 28 
4 CR 280 28 
5 CR 280 28 
6 CR 300 30 
7 NR 540 
8 CR 380 38 
9 CR 440 44 
10 CR 280 28 
11 CR 280 28 Daunorubicin (40 mg/d × 3 d) + Ara-C (150 mg/d × 5 d) 
12 CR 390 39 ATRA 30 mg/d, from day 11 to CR 
13 CR 530 53 Hydroxyurea (3 g/d × 15 d) 
14 CR 420 42 ATRA 30 mg/d, from day 3 
to CR 
15 CR 540 54 Harringtonine (4 mg × 25 d) + Ara-C (200 mg/d × 9 d) 
Patient No.Treatment ResultsTotal Doses of As2O3 UsedDays to Achieve CRAdditional Treatment
1 CR 280 28 
2 CR 410 41 
3 CR 280 28 
4 CR 280 28 
5 CR 280 28 
6 CR 300 30 
7 NR 540 
8 CR 380 38 
9 CR 440 44 
10 CR 280 28 
11 CR 280 28 Daunorubicin (40 mg/d × 3 d) + Ara-C (150 mg/d × 5 d) 
12 CR 390 39 ATRA 30 mg/d, from day 11 to CR 
13 CR 530 53 Hydroxyurea (3 g/d × 15 d) 
14 CR 420 42 ATRA 30 mg/d, from day 3 
to CR 
15 CR 540 54 Harringtonine (4 mg × 25 d) + Ara-C (200 mg/d × 9 d) 

Abbreviation: NR, no remission.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal